Article Details

Fresh disappointment for Innate's Astra lifeline - Evaluate Pharma

Retrieved on: 2022-08-01 20:44:35

Tags for this article:

Click the tags to see associated articles and topics

Fresh disappointment for Innate's Astra lifeline - Evaluate Pharma. View article details on hiswai:

Excerpt

The October 2018 cross-licence with Astrazeneca had seemed like a fresh start for Innate Pharma after the failure of the Bristol Myers ...

Article found on: www.evaluate.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up